4//SEC Filing
Borthwick Kathleen 4
Accession 0001415889-24-003640
CIK 0001787297other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 7:36 PM ET
Size
9.1 KB
Accession
0001415889-24-003640
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2024-02-13$0.97/sh−1,470$1,426→ 28,466 total - Exercise/Conversion
Restricted Stock Unit
2024-02-10−4,000→ 8,000 total→ Common Stock (4,000 underlying) - Exercise/Conversion
Common Stock
2024-02-10+4,000→ 29,936 total
Footnotes (3)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a "sell to cover" transaction.
- [F3]1/3 of the RSUs will vest on February 10, 2024 and 2/3 of the RSUs will vest on February 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Documents
Issuer
Passage BIO, Inc.
CIK 0001787297
Entity typeother
Related Parties
1- filerCIK 0001987062
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 7:36 PM ET
- Size
- 9.1 KB